Yuwell Global

Yuwell Medical, which has been focusing on medical and health care for 25 years, was founded in 1998, and in 2008 became the first privately owned medical device company to list on a Mainland Chinese stock exchange. Yuwell’s guiding principle is to build up a comprehensive and professional medical service platform, bringing professional medical technologies and advanced product solutions into daily life, creating a health ecosystem merging homecare, clinical treatment and online solutions. Yuwell Medical has established 12 R&D centers and 9 production bases in Shanghai, Shenzhen, Nanjing, Suzhou, Danyang, Tibet, the Netherlands, Germany, Italy, and other places, forming a complete global R&D, production, marketing, and service network that serve more than 300,000 medical institutions worldwide and covers 131 countries and regions overseas, benefitting 300 million households around the world. Yuwell works with Chinese medical agencies and key medical experts to establish industry standards and provide outstanding products within the homecare and chronic disease management fields. It covers 10 medical and health solutions including respiratory therapy, diabetes management, in vitro diagnosis, infection control, ultrasound diagnostics, and others. In many of the above product lines, Yuwell has been the #1 brand in the China market for many years. In terms of manufacturing, Yuwell Medical's global manufacturing base covers an area of 670,000 sq.m., with the Group having invested $500 million into these facilities over a 5 year period. In line with Industry 4.0 and intelligent manufacturing standards, it has created an intelligent collaborative production system integrating a CNAS approved national product laboratory, intelligent manufacturing, digital workshops, flexible production lines, unmanned logistics warehousing, digital user services. In the future, Yuwell will focus on medical health, devote itself to life science research and application.